Home
½ÃÀÛÆäÀÌÁö
Áö³È£º¸±â
·Î±×ÀÎ
ȸ¿ø°¡ÀÔ
±¸µ¶½Åû
Àüü±â»ç
2024-03-29 ±Ý 13:56
±â»ç°Ë»ö
Cover Story
¼øȯ±â
³»ºÐºñ
È£Èí±â
¼Òȱâ
½Å°æ°ú
Á¤½Å°Ç°
°¨¿°³»°ú
Sub Story
Interview
Drug Review
Conference Report
Late Breaking Studies
Expert Opinion
Primary Expert Opinion
The Rare Disease
ÇмúÀÚ¹®À§¿ø
RTM
»ó´Ü¿©¹é
񃯇
(Àüü 890°Ç)
Á¦¸ñº¸±â
Á¦¸ñº¸±â
Á¦¸ñ+³»¿ë
[Sub Story]
2015 ´ëÇÑõ½Ä¾Ë·¹¸£±âÇÐȸ Áø·áÁöħ
ÀÓ¼¼Çü ±âÀÚ
2016-04-28 15:19
[Sub Story]
ÁßÁõõ½Ä, Æä³ëŸÀÔ¿¡ µû¸¥ Ÿ±êÄ¡·á ÁöÇâ
ÀÓ¼¼Çü ±âÀÚ
2016-04-28 15:12
[Sub Story]
¡®Áõ»ó¡¯À¸·Î¼ ±âħ Áö¼Ó±â°£ µû¶ó °ü¸®
ÀÓ¼¼Çü ±âÀÚ
2016-04-28 15:05
[Cover Story]
°°Àº µí ´Ù¸¥ È£Èí±âÁúȯÀÇ ¹Ì·Î
ÀÓ¼¼Çü ±âÀÚ
2016-04-12 17:22
[Sub Story]
Áõ»ó¡¤¾ÇÈ¡¤Æó±â´É ÅëÇÕÀû Æò°¡ ÅëÇØ È¯ÀÚ±º ºÐ·ù
ÀÓ¼¼Çü ±âÀÚ
2016-04-12 17:20
¶óÀÎ
[Sub Story]
õ½Ä°ú COPDÀÇ ÀÓ»óÀû Áߺ¹ÁöÁ¡, ACOS
ÀÓ¼¼Çü ±âÀÚ
2016-04-12 17:19
[Sub Story]
Phenotype rather than Syndrome?
ÀÓ¼¼Çü ±âÀÚ
2016-04-12 17:18
[Sub Story]
IPF Ä¡·áÀü·«À¸·Î ´ÑÅ×´Ù´Õ¡¤ÇǸ£Æä´Ïµ·¡¤Á¦»êÁ¦ ±Ç°í
ÀÓ¼¼Çü ±âÀÚ
2016-04-12 17:16
[Interview]
¡°»è»ç±Û¸³Æ¾, ¾ÈÀü¼º ´ãº¸µÈ DPP-4 ¾ïÁ¦Á¦¡±
ÀÓ¼¼Çü ±âÀÚ
2016-04-12 16:53
[Interview]
¡°Æä³ëÇǺ극ÀÌÆ®, Àν¶¸° ÀúÇ×¼º ÀÌ»óÁöÁúÇ÷Áõ °ü¸®ÀÇ ¶Ç´Ù¸¥ Çٽɡ±
ÀÓ¼¼Çü ±âÀÚ
2016-04-12 15:04
¶óÀÎ
[Sub Story]
Combination Therapy - Diabetes
ÀÓ¼¼Çü ±âÀÚ
2016-04-12 14:54
[Sub Story]
Ç÷´ç°ÇÏÁ¦ º´¿ë¿ä¹ýÀÇ È¿°ú
ÀÓ¼¼Çü ±âÀÚ
2016-04-12 14:48
[Sub Story]
ÃÊÄ¡·á Áö¼ÓÀû Ç÷´ç°ÇÏ ÀÔÁõ
ÀÓ¼¼Çü ±âÀÚ
2016-04-12 14:38
[Sub Story]
º´¿ë¿ä¹ý À§ÇÑ ¡®Ãֽš¯ÀÇ ÆÛÁñÁ¶°¢
ÀÓ¼¼Çü ±âÀÚ
2016-04-12 14:32
[Sub Story]
Àν¶¸° ºÐºñ´É¡¤ÀúÇ×¼º Ÿ±ê Àå±â°£ Ç÷´çÁ¶Àý
ÀÓ¼¼Çü ±âÀÚ
2016-04-12 14:28
¶óÀÎ
[Conference Report]
2016 ±¹Á¦³úÁ¹ÁßÇмú´ëȸ ÇÏÀ϶óÀÌÆ®
ÀÓ¼¼Çü ±âÀÚ
2016-04-12 13:39
[Hot Discussion]
CÇü°£¿° À¯ÀüÀÚÇü 1bÇü¿¡ ´ëÇÑ È¿°ú ÀçÈ®ÀÎ
ÀÓ¼¼Çü ±âÀÚ
2016-04-12 13:30
[Hot Discussion]
¼ÒÆ÷½ººÎºñ¸£ Ãß°¡ ÀÓ»óÅëÇØ ¿µ¿ªÈ®Àå
ÀÓ¼¼Çü ±âÀÚ
2016-04-12 13:22
[Sub Story]
Çѱ¹Çü ´ç´¢º´ °ü¸® º´¿ë¿ä¹ýÀ¸·Î ±Í°á
ÀÓ¼¼Çü ±âÀÚ
2016-03-07 11:00
[Hot Discussion]
½Å±Ô º´¿ë¿ä¹ý¡¤º¹ÇÕÁ¦ CÇü°£¿° Ä¡·á Æз¯´ÙÀÓ ¹Ù²Ù´Ù
ÀÓ¼¼Çü ±âÀÚ
2016-03-07 10:47
-
ÀÌÀü
41
42
43
44
45
-
¿©¹é
Sub
news
¡°ACEI ÀÓ»ó±Ù°Å ³õ°í, ȯÀÚ ¼³µæÇÏÀÚ¡±
Q. Ç÷¾Ð°ÇÏ Ãø¸é¿¡¼ ACEIÀÇ Æ¯¼ºÀº?ù...
¡°SGLT-2i Ȳ±Ý±â´Â TZD¿Í º´¿ëÀ¸·ÎºÎÅÍ¡±
Q. SGLT-2iÀÇ °è¿È¿°ú¿¡ ´ëÇÑ °ßÇØ´Â...
¡°°í°µµ ½ºÅ¸Æ¾ Á¦Á¦ È¿°ú ´ëµîÇϳª ¾ÈÀü¼º ´Ù¸¦ ¼öµµ¡±
Q. CAD ȯÀÚÀÇ ÀÌ»óÁöÁúÇ÷Áõ Ä¡·áÀü·«Àº?...
¿©¹é
¿©¹é
Back to Top